Wael Fayad

Director/Board Member at

Crown Laboratories, Inc.

Health Technology

Consumer Services

Finance

Profile

Wael Fayad is the founder of Accoy Pharmaceuticals, Inc. (founded in 2015).
He is currently the Director at Crown Laboratories, Inc. (since 2020) and a Partner at Hildred Capital Management LLC (since 2018).
Previously, he served as the Chairman of Enumeral Biomedical Holdings, Inc. (2017-2018) and held a position as Vice President-Global Business Development at Forest Laboratories, Inc. Mr. Fayad holds an MBA from Concordia University (conferred in 1993) and an undergraduate degree from the American University of Beirut (conferred in 1989).

Wael Fayad active positions

Companies	Position	Start
Hildred Capital Management LLC Hildred Capital Management LLC Investment ManagersFinance Hildred Capital invests in middle market companies located in the United States with an enterprise value of USD 50 - 500 million and revenues of USD 10 - 100 million. The firm targets companies operating in the fields of healthcare services, consumer products, information technology, medical devices and pharmaceuticals products sectors. It provides financing for growth and buyout stage capital transactions with an investment size of USD 25 - 300 million. The firm also acquires majority and minority stake positions.	Private Equity Investor	2018-04-30
Crown Laboratories, Inc. Crown Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets consumer skincare, prescription dermatology and aesthetic treatment products	Director/Board Member	2020-01-31

All active positions of Wael Fayad

Former positions of Wael Fayad

Companies	Position	End
Accoy Pharmaceuticals, Inc.	Founder	2019-08-31
ENUMERAL BIOMEDICAL HOLDINGS INC	Chief Executive Officer	2017-06-28
FOREST LABORATORIES, INC.	Corporate Officer/Principal	-

See the detail of Wael Fayad's experience

Training of Wael Fayad

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Wael Fayad's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Crown Laboratories, Inc. Crown Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets consumer skincare, prescription dermatology and aesthetic treatment products	Health Technology
Forest Laboratories, Inc. Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products	Health Technology
Enumeral Biomedical Holdings, Inc. Enumeral Biomedical Holdings, Inc. BiotechnologyHealth Technology Develops novel antibody immunotherapies designed to help immune system attack diseased cells	Health Technology
Concordia University Concordia University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
American University of Beirut American University of Beirut Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Hildred Capital Management LLC Hildred Capital Management LLC Investment ManagersFinance Hildred Capital invests in middle market companies located in the United States with an enterprise value of USD 50 - 500 million and revenues of USD 10 - 100 million. The firm targets companies operating in the fields of healthcare services, consumer products, information technology, medical devices and pharmaceuticals products sectors. It provides financing for growth and buyout stage capital transactions with an investment size of USD 25 - 300 million. The firm also acquires majority and minority stake positions.	Finance
Accoy Pharmaceuticals, Inc.

See company connections